| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $50K | +127.3% | -51.9% |
| Cost of Revenue | $103K | -4.6% | -66.3% |
| Gross Profit | -$53K | +38.4% | +73.8% |
| R&D Expense | $3.1M | -16.6% | -18.7% |
| SG&A Expense | $4.1M | -6.2% | +7.3% |
| Operating Income | -$7.8M | +10.1% | +0.3% |
| Income Tax | $2K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $43.0M | +1712.8% | +635.5% |
| Accounts Receivable | $56K | +107.4% | -26.3% |
| Inventory | $884K | +281.0% | +242.6% |
| Current Assets | $86.2M | +322.3% | +255.5% |
| Total Assets | $87.5M | +296.1% | +232.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$20.2M | — | — |
| Capital Expenditures | $52K | — | — |
| Investing Cash Flow | -$29.2M | — | — |
| Financing Cash Flow | $82.2M | — | — |
| Free Cash Flow | -$20.3M | — | — |
| — |
| — |
| Net Income | -$9.3M | -0.6% | -7.2% |
| EPS (Basic) | -$0.30 | +37.5% | +70.3% |
| $8.1M |
| -23.6% |
| -24.5% |
| Total Liabilities | $9.4M | -21.5% | -18.4% |
| Stockholders' Equity | $78.2M | +667.9% | +424.6% |